HealthCCSng vs Zio AT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Nano-X AI
VS
by iRhythm Technologies, Inc.

AI Verdict

HealthCCSng is designed to assess the risk of coronary artery disease by detecting and quantifying coronary artery calcification from routine CT scans. In contrast, the Zio AT ECG Monitoring System focuses on identifying cardiac arrhythmias through continuous, long-term wearable ECG monitoring. While both leverage AI in cardiology, they address distinct clinical needs and utilize different diagnostic modalities.

Choose HealthCCSng if…

Choose HealthCCSng if you need to proactively assess a patient's risk of coronary artery disease by leveraging existing routine chest CT scans. This tool is ideal for automatically detecting and quantifying coronary artery calcification (CAC) to identify at-risk individuals without requiring additional dedicated scans. It provides a numerical calcium score and visualizes calcified plaques, integrating seamlessly into existing radiology workflows.

View HealthCCSng →

Choose Zio AT ECG Monitoring System if…

Choose Zio AT ECG Monitoring System if you need continuous, long-term monitoring for arrhythmia detection in patients experiencing or suspected of having cardiac events. This wearable system is best suited for identifying both symptomatic and asymptomatic arrhythmias over an extended period (up to 14 days), providing comprehensive ECG data and AI-powered analysis for a detailed diagnostic report.

View Zio AT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature HealthCCSng Zio AT ECG Monitoring System
Pricing Not publicly available Contact for pricing
Deployment Cloud-based, integrates with PACS and EMR systems Cloud-based (data analytics and clinician portal)
BAA Available Unknown Yes AI-estimated
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

HealthCCSng

HealthCCSng offers a highly streamlined user experience by integrating seamlessly into existing radiology workflows and automatically analyzing routine CT scans without requiring additional patient interaction or dedicated procedures. In contrast, Zio AT, while designed for patient convenience, necessitates patient compliance with a wearable device and clinician interaction with a separate portal for management and reporting.

Clinical Value

Tie

Both tools provide significant, yet distinct, clinical value. HealthCCSng excels at opportunistic risk stratification for coronary artery disease by detecting and quantifying CAC from routine CT scans. Zio AT offers comprehensive, long-term, real-time arrhythmia detection through a wearable, addressing a different critical aspect of cardiac care.

Pricing & Value

Zio AT ECG Monitoring System

While neither tool publicly discloses exact pricing, Zio AT provides more transparency regarding its billing model, including service fees, CPT codes, insurance coverage, and patient financial assistance programs. Furthermore, Zio AT has published health economic studies demonstrating its value. HealthCCSng mentions CPT codes and revenue generation potential but lacks detailed information on its pricing structure or patient cost management.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, and cloud-based deployment. HealthCCSng's fully automated workflow and seamless integration with PACS and EMR systems are ideal for radiology departments. Zio AT's end-to-end service model, including EHR integration and patient management features, also caters well to broader healthcare systems.

Innovation

Tie

Both tools present compelling innovations in their respective fields. HealthCCSng innovates by leveraging AI to extract critical cardiac risk information from routine, opportunistic CT scans, making CAD risk assessment more accessible. Zio AT's combination of a long-duration wearable, real-time data transmission, and a highly accurate deep-learned AI for arrhythmia detection represents a significant advancement in ambulatory cardiac monitoring.

Support & Docs

Zio AT ECG Monitoring System

Zio AT clearly outlines multiple support channels, including dedicated customer care lines for both patients and providers, and provides comprehensive documentation such as clinical reference manuals and instructions for use. HealthCCSng lacks publicly available information regarding its support and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature HealthCCSng Zio AT ECG Monitoring System
Primary Function Analyzes routine CT scans to automatically detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease. Wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting.
AI-Powered yes yes
Target Condition/Analysis Coronary Artery Calcification (CAC) / Coronary Artery Disease risk Arrhythmia detection / Cardiac events
Data Source/Methodology Routine CT scans (non-contrast, non-ECG gated chest CT scans) Continuous ECG recording via wearable Zio AT patch
Key Output Numerical calcium score, categorization into 'zero', 'low', 'moderate', 'severe' CAC, visualization of calcified plaques. Comprehensive end-of-wear reports for clinicians, detection of symptomatic and asymptomatic cardiac events.
Categories Cardiology AI Cardiology AI, Wearables & Remote Monitoring (RPM)

Videos

Demos, reviews, and walkthroughs featuring HealthCCSng and Zio AT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

HealthCCSng leverages existing non-contrast, non-ECG gated chest CT scans for automated CAC detection, minimizing additional patient burden and integrating into existing radiology workflows for coronary artery disease risk assessment. Zio AT requires patient adherence to a wearable patch for up to 14 days, providing continuous ECG data for comprehensive arrhythmia detection, which involves patient education and clinician portal review for interpretation of symptomatic and asymptomatic events.
HealthCCSng offers seamless integration with PACS and EMR systems, providing automated results and visualizations of calcified plaques directly into the patient's record without human intervention. Zio AT utilizes a ZioSuite clinician portal for report interpretation and patient management, with comprehensive end-of-wear reports typically integrated with EMRs for clinician access and review.
HealthCCSng's AI-powered solution automatically detects and quantifies coronary artery calcification from CT scans, categorizing studies into risk levels (zero, low, moderate, severe) and generating a numerical calcium score. Zio AT's FDA-cleared deep-learned AI algorithm (ZEUS System) is specifically designed for continuous, uninterrupted ECG recording to detect and report both symptomatic and asymptomatic cardiac events over an extended monitoring period.
HealthCCSng is best suited for identifying patients at risk of coronary artery disease by assessing coronary artery calcification from routine chest CTs, aiding in primary prevention strategies and risk stratification. Zio AT is ideal for patients requiring long-term monitoring for suspected or known arrhythmias, providing comprehensive data on cardiac events over up to 14 days to guide diagnosis and treatment.
HealthCCSng's automated analysis of existing CT scans and seamless integration suggest a low learning curve for result interpretation and rapid time-to-value by leveraging existing imaging data for immediate CAD risk assessment. Zio AT involves patient education for wearable use and navigation of the ZioSuite clinician portal, with clinical value realized through comprehensive arrhythmia reports after the monitoring period, which can be up to 14 days.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.